US EditionPublished • loading... • Updated
The Hospital De Jerez Continues with Its Improvements and Achieves Great Advances in Cell Therapies
Summary by lavozdelsur.es
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The University Hospital of Jerez, dependent on the Andalusian Health Service (SAS), has strengthened during 2025 the capacity of its Hematology Service after successfully completing different qualification and auditing processes for the realization of lymphocyte apheresis, essential for the generation of CAR-T products. At the beginning of last year, the Apheresis Unit of the hospital was qualified
The centre has obtained the qualification of three major pharmaceutical companies — Kite/Gilead, Bristol Myers Squibb (BMS) and Johnson & Johnson — for the extraction of cells for advanced therapy The northwestern part of Jerez has a new green zone: a green zone.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
